Alternatives to Variantyx

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

AI-powered spatial biology platform for precision medicine and drug development.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

Israeli-UK biotech company developing novel RNA therapeutics for rare genetic diseases.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Leveraging proteomic pattern analysis to personalize cancer treatment and improve patient outcomes.

Making targeted DNA sequencing as common, fast, and affordable as a blood test.

AI-driven drug discovery platform accelerating breakthrough scientific research.

Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations.

Bioinformatics platform for rapid discovery and validation of precision mental health treatments.

MeMed develops and commercializes host immune response diagnostic solutions to address complex clinical dilemmas and improve patient outcomes.

Data-driven drug discovery and development company using machine learning and high-throughput biology.

Personalized diagnostics for cancer genomic markers at the point of treatment.

Pioneering volatile markers (VM) tests for early cancer detection in large-scale populations.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.

Biotech company using AI and deep RNA analysis to predict cancer treatment response.

Developing a liquid biopsy blood test for early disease detection and monitoring using epigenetic information.

Scent-based multi-cancer early detection screening test using AI and bio-detectors.

Develops toilet-integrated diagnostic technology for early health condition detection.